With this approval, Roche’s automated mass spectrometry platform now offers the industry’s broadest in vitro diagnostic menu with 39 tests, including tests for therapeutic drug monitoring for ...

Roche Diagnostics India announced the launch of latest diagnostic technology - cobas pro integrated solutions - which brings to India’s IVD labs an opportunity to establish several ‘first-of-its-kind’ ...

Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn. PathAI specialises in digital pathology and AI-powered diagnostics, serving ...

Roche will unveil the next generation of its serum work area, several molecular systems and the cobas ® connection module. The company will introduce navify ® digital solutions that help laboratories ...

Laboratory Corporation of America® Holdings (LabCorp®) has announced an agreement to offer a HIV test for diagnostic use. LabCorp is the first commercial laboratory to enter a supply agreement for ...

BETHLEHEM, Pa., March 3, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) and Roche announced today that the U.S. Food and Drug Administration ("FDA") has granted the Companies 510(k) ...

Roche launched a relatively more compact addition to its mainstay cobas molecular diagnostic lineup with instruments that aim to bring automated testing to laboratories of all sizes. Roche is ...

Test developed by Ventana subsidiary is carried out on an automated slide preparation system and detects both Her2 and chromosome 17. FDA has approved Ventana Medical Systems’ Inform Her2 Dual ISH DNA ...

BASEL, Switzerland, May 27, 2024 /PRNewswire/ -- Roche announced today that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.

Roche is a biopharmaceutical company that has been in business for more than 124 years globally, and 40 years in Ecuador. By combining science and research, from diagnosis to treatment of multiple ...